February 25, 2021
Appili Therapeutics to Host Drs. Scott Gottlieb and Syra Madad in Virtual Fireside Chat Discussing COVID-19: What We’ve Learned About Pandemic Responses, and Where We Go From Here
Read More
February 24, 2021
Appili Therapeutics to Present as Part of Canada’s Top Three Pitches at Biocom’s Global Life Science Partnering Conference Today
Read More
February 18, 2021
Appili Therapeutics to Host Series of Virtual Fireside Chats; First Event to Feature Dr. Scott Gottlieb to Discuss Critical Need for More Options to Combat COVID-19
Read More
February 12, 2021
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2021
Read More
February 2, 2021
Appili Therapeutics Appoints Veteran Healthcare Executive Rochelle Stenzler to its Board of Directors
Read More
January 28, 2021
Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
Read More
January 6, 2021
Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference
Read More